AstraZeneca PLC Director/PDMR Shareholding (8249F)

TIDMAZN

RNS Number : 8249F

AstraZeneca PLC

01 August 2016

Transaction by Person Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

On 1 August 2016, the interest of Marc Dunoyer, a person discharging managerial responsibilities, in the ordinary shares of AstraZeneca PLC changed as detailed below.

The change in interest relates to the vesting of awards of shares made in August 2013 under the AstraZeneca Performance Share Plan and the AstraZeneca Restricted Share Plan.

Following the application of performance measures specified at the time of grant, Mr Dunoyer has become beneficially entitled to 78% of the shares originally awarded. In accordance with the plan rules, any unvested part of the award has immediately and irrevocably lapsed.

After sufficient vested shares were withheld to satisfy certain tax obligations arising on the vesting, Mr Dunoyer has become beneficially entitled to and has received 43,730 shares into a personal brokerage account.

For tax purposes, the fair market value of the shares at vest was 5048 pence per share being the closing price of AstraZeneca ordinary shares on the last trading day preceding the vesting day.

The attached notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1    Details of the person discharging managerial 
       responsibilities / person closely associated 
---  --------------------------------------------------------------- 
 a)   Name                       Marc Dunoyer 
---  -------------------------  ------------------------------------ 
 2    Reason for the notification 
---  --------------------------------------------------------------- 
 a)   Position/status            Chief Financial Officer 
---  -------------------------  ------------------------------------ 
 b)   Initial notification       Initial notification 
       /Amendment 
---  -------------------------  ------------------------------------ 
 3    Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
---  --------------------------------------------------------------- 
 a)   Name                       AstraZeneca PLC 
---  -------------------------  ------------------------------------ 
 b)   LEI                        Not applicable 
---  -------------------------  ------------------------------------ 
 4    Details of the transaction(s): section to 
       be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  --------------------------------------------------------------- 
 a)   Description of             Ordinary Shares of US$0.25 
       the financial              each in AstraZeneca PLC 
       instrument, type 
       of instrument 
                                  GB0009895292 
       Identification 
       code 
---  -------------------------  ------------------------------------ 
 b)   Nature of the              Acquisition of Ordinary Shares 
       transaction                pursuant to a vesting of 
                                  awards under the AstraZeneca 
                                  Performance Share Plan and 
                                  the AstraZeneca Restricted 
                                  Share Plan 
---  -------------------------  ------------------------------------ 
 c)   Price(s) and volume(s)       Price(s)      Volume(s) 
                                   ------------  ---------- 
                                    5048 pence    43,730 
                                   ------------  ---------- 
---  -------------------------  ------------------------------------ 
 d)   Aggregated information     Not applicable - single transaction 
 
 
       - Aggregated volume 
 
 
       - Price 
---  -------------------------  ------------------------------------ 
 e)   Date of the transaction    1 August 2016 
---  -------------------------  ------------------------------------ 
 f)   Place of the transaction   London 
---  -------------------------  ------------------------------------ 
 

A C N Kemp

Company Secretary

1 August 2016

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHUAOKRNBAWRRR

(END) Dow Jones Newswires

August 01, 2016 06:00 ET (10:00 GMT)